National Pension Service Purchases 8,546 Shares of Humana Inc. (NYSE:HUM)

National Pension Service grew its position in shares of Humana Inc. (NYSE:HUM) by 3.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 291,916 shares of the insurance provider’s stock after purchasing an additional 8,546 shares during the quarter. National Pension Service’s holdings in Humana were worth $133,642,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of HUM. Morgan Stanley raised its stake in shares of Humana by 6.2% during the third quarter. Morgan Stanley now owns 2,040,896 shares of the insurance provider’s stock worth $992,938,000 after acquiring an additional 119,760 shares in the last quarter. Ameriprise Financial Inc. lifted its stake in Humana by 35.9% in the third quarter. Ameriprise Financial Inc. now owns 1,523,835 shares of the insurance provider’s stock worth $741,409,000 after purchasing an additional 402,559 shares during the last quarter. Northern Trust Corp boosted its position in Humana by 5.1% during the third quarter. Northern Trust Corp now owns 1,327,489 shares of the insurance provider’s stock valued at $645,850,000 after buying an additional 64,245 shares during the period. Invesco Ltd. grew its stake in shares of Humana by 1.4% during the third quarter. Invesco Ltd. now owns 965,488 shares of the insurance provider’s stock valued at $469,729,000 after buying an additional 13,670 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. increased its holdings in shares of Humana by 3.4% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 818,040 shares of the insurance provider’s stock worth $374,507,000 after buying an additional 26,879 shares during the period. 92.38% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, Director Jorge S. Mesquita purchased 545 shares of the business’s stock in a transaction that occurred on Tuesday, February 20th. The shares were bought at an average price of $367.09 per share, for a total transaction of $200,064.05. Following the purchase, the director now directly owns 2,578 shares of the company’s stock, valued at approximately $946,358.02. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.29% of the company’s stock.

Analysts Set New Price Targets

HUM has been the subject of several analyst reports. Cantor Fitzgerald dropped their target price on Humana from $391.00 to $360.00 and set a “neutral” rating for the company in a report on Thursday, April 25th. Barclays decreased their target price on shares of Humana from $356.00 to $310.00 and set an “equal weight” rating on the stock in a research note on Tuesday, April 2nd. Mizuho dropped their price target on shares of Humana from $550.00 to $400.00 and set a “buy” rating for the company in a research report on Friday, January 26th. Deutsche Bank Aktiengesellschaft cut shares of Humana from a “buy” rating to a “hold” rating and decreased their price objective for the company from $595.00 to $360.00 in a research report on Thursday, January 25th. Finally, Truist Financial reiterated a “hold” rating and set a $550.00 target price on shares of Humana in a report on Friday, January 19th. Eleven investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat, Humana has a consensus rating of “Hold” and an average target price of $424.50.

Humana Stock Down 0.2 %

HUM stock traded down $0.49 during midday trading on Wednesday, hitting $324.14. The stock had a trading volume of 1,278,149 shares, compared to its average volume of 1,967,296. The business has a 50-day moving average of $323.08 and a two-hundred day moving average of $385.94. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.67 and a quick ratio of 1.67. The firm has a market cap of $39.06 billion, a price-to-earnings ratio of 20.18, a price-to-earnings-growth ratio of 1.86 and a beta of 0.49. Humana Inc. has a 52-week low of $298.61 and a 52-week high of $541.21.

Humana (NYSE:HUM) last released its earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share for the quarter, topping analysts’ consensus estimates of $6.12 by $1.11. The firm had revenue of $29.61 billion for the quarter, compared to the consensus estimate of $28.52 billion. Humana had a net margin of 1.82% and a return on equity of 17.76%. The company’s revenue was up 10.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $9.38 EPS. As a group, equities research analysts forecast that Humana Inc. will post 16.18 earnings per share for the current fiscal year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.09%. The ex-dividend date of this dividend is Friday, June 28th. Humana’s dividend payout ratio is 22.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.